Daniel J. DeAngelo, MD, PhD | Authors


Overview of 4 FDA Approvals in Acute Myeloid Leukemia

May 16, 2018

Daniel J. DeAngelo, MD, PhD, associate professor at the Harvard School of Medicine and a member of the Adult Leukemia Program at Dana-Farber Cancer Institute, highlighted the 4 FDA approvals in the last year for the treatment of patients with acute myeloid leukemia.